×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
Introduction
Dr Leïla Bengrine-Lefevre
18:05
Les nouvelles recommandations St-Paul-de-Vence appliquées en vraie vie:
  • Cas clinique d’une patiente en première ligne d’un cancer de l’ovaire avancé
    Dr Fernando Bazan
     
  • Cas Clinique d’une patiente en rechute d’un cancer de l’ovaire avancé
    Dr Leïla Bengrine-Lefevre
19:05
Défauts de la recombinaison homologue (HRD):  définition et perspectives thérapeutiques
Dr Elisabeth Luporsi
19:25
La chirurgie à l’ère des PARP Inhibiteurs
Pr Chérif Akladios
19:55 Conclusion

 

Shooting date : 2021-07-12
Last update : 2021-12-23
1 comment
Join the Discussion
  • mohamed S. merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 15th 2025 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, April 15th 2025 from 10am to 11:30am (GMT+2)
    New York : Tuesday, April 15th 2025 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, April 15th 2025 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, April 15th 2025 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 15th 2025 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, April 15th 2025 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 15th 2025 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, April 16th 2025 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, April 16th 2025 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, April 16th 2025 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, April 16th 2025 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, April 16th 2025 from 06am to 07:30am (GMT+2)

    Outils utiles aux cliniciens durant la chimio néoadjuvante des cancers de l’ovaire

    Share
    Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Honolulu : Wednesday, May 21st 2025 from 10pm to 07:30am (GMT+2)
    San Francisco : Thursday, May 22nd 2025 from 01am to 10:30am (GMT+2)
    New York : Thursday, May 22nd 2025 from 04am to 01:30pm (GMT+2)
    Buenos Aires : Thursday, May 22nd 2025 from 05am to 02:30pm (GMT+2)
    Reykjavik : Thursday, May 22nd 2025 from 08am to 05:30pm (GMT+2)
    London / Dublin : Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Paris / Berlin : Thursday, May 22nd 2025 from 10am to 07:30pm (GMT+2)
    Istanbul : Thursday, May 22nd 2025 from 11am to 08:30pm (GMT+2)
    Moscou / Dubaï : Thursday, May 22nd 2025 from 12pm to 09:30pm (GMT+2)
    Bangkok : Thursday, May 22nd 2025 from 03pm to 12:30am (GMT+2)
    Shanghai : Thursday, May 22nd 2025 from 04pm to 01:30am (GMT+2)
    Tokyo : Thursday, May 22nd 2025 from 05pm to 02:30am (GMT+2)
    Sydney : Thursday, May 22nd 2025 from 07pm to 04:30am (GMT+2)
    Wellington : Thursday, May 22nd 2025 from 09pm to 06:30am (GMT+2)

    16e congrès de la SFCO

    Rediffusion en direct

    Share
    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Tuesday, January 13th 2026 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, January 13th 2026 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, January 13th 2026 from 09am to 10:30am (GMT+1)
    New York : Tuesday, January 13th 2026 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, January 13th 2026 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, January 13th 2026 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, January 13th 2026 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, January 13th 2026 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, January 13th 2026 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, January 14th 2026 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, January 14th 2026 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, January 14th 2026 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, January 14th 2026 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, January 14th 2026 from 05am to 06:30am (GMT+1)

    Place de l'IA dans la prise en charge du cancer de l'ovaire

    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 07:30am to 09am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 10:30am to 12pm (GMT+2)
    New York : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 09:30pm to 11pm (GMT+2)
    Bangkok : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 02:30am to 04am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 04:30am to 06am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 06:30am to 08am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Scroll Up